A clinical trial using focused ultrasound medial thalamotomy to treat patients with chronic pain showed sustained pain relief over time.
The 55 participants enrolled presented with spinal cord injury, trigeminal neuralgia, post-discectomy radiculopathy, and other types of nerve-related pain.
One year after treatment, half of the participants had stopped taking opioid pain relievers.
A collaborative team used focused ultrasound to open the blood-brain barrier and enhance delivery of mitochondria to the brain cells in a preclinical model of stroke.
The treatment decreased the cerebral infarction volume and increased cell survival and function.
In this eighth blog in the series, Mark Carol, MD, a senior consultant at the Foundation, addresses the importance of garnering support from professional societies and technology assessment associations.
He explains why additional data may be required before new procedures are incorporated into official clinical guidelines.
“[Dr. Gallay’s study] might be the longest period of follow up for focused ultrasound treatment of neuropathic pain to date. The sustained pain relief and reduction in opioid use are incredibly impactful findings. ”
‒ Tim Meakem, MD, the Foundation’s chief medical officer
We use cookies to optimize our website and our service.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
By using FUSF’s AI agent, you acknowledge and agree that your use is governed by FUSF’s Terms of Use Agreement. If you do not agree to be bound by the Terms of Use Agreement, you may not access or use FUSF’s AI agent.
